D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XM
2751
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $2.13M | ﹤0.01% |
204,947
-83,528
| -29% | -$875K |
|
2752
Novartis
NVS
$294B
| $2.13M | ﹤0.01% |
23,443
+16,678
| +247% | +$1.4M |
|
|
FTPA
2753
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $2.13M | ﹤0.01% |
211,870
| – | – |
|
2754
CRA International
CRAI
$1.14B
| $2.12M | ﹤0.01% |
17,356
+7,489
| +76% | +$825K |
|
2755
PUT
Allegiant Air
ALGT
$2.79B
| $2.12M | ﹤0.01% |
31,200
+12,900
| +70% | +$941K |
|
2756
Pacific Biosciences
PACB
$404M
| $2.12M | ﹤0.01% |
258,673
+82,812
| +47% | +$714K |
|
|
AVEO
2757
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.11M | ﹤0.01% |
141,202
-124,680
| -47% | -$1.73M |
|
2758
CALL
Jefferies Financial Group
JEF
$13B
| $2.11M | ﹤0.01% |
64,329
| – | – |
|
|
ROCL
2759
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $2.11M | ﹤0.01% |
208,500
| – | – |
|
2760
CALL
Repligen
RGEN
$8.95B
| $2.1M | ﹤0.01% |
12,400
-8,000
| -39% | -$1.45M |
|
2761
Beazer Homes USA
BZH
$931M
| $2.1M | ﹤0.01% |
164,385
+101,280
| +160% | +$1.23M |
|
2762
Ecovyst
ECVT
$1.25B
| $2.1M | ﹤0.01% |
236,512
-108,126
| -31% | -$996K |
|
|
ATEK
2763
DELISTED
Athena Technology Acquisition Corp. II
ATEK
| $2.09M | ﹤0.01% |
207,878
| – | – |
|
2764
Huron Consulting
HURN
$2.38B
| $2.09M | ﹤0.01% |
28,800
-3,366
| -10% | -$248K |
|
2765
TTEC Holdings
TTEC
$128M
| $2.09M | ﹤0.01% |
47,293
+9,157
| +24% | +$411K |
|
2766
PUT
Citizens Financial Group
CFG
$31.1B
| $2.08M | ﹤0.01% |
52,800
| – | – |
|
|
CITE
2767
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $2.07M | ﹤0.01% |
200,000
| – | – |
|
2768
Amalgamated Financial
AMAL
$1.5B
| $2.07M | ﹤0.01% |
89,861
+12,457
| +16% | +$302K |
|
2769
New Fortress Energy
NFE
$95.4M
| $2.07M | ﹤0.01% |
48,778
-554,649
| -92% | -$26.8M |
|
2770
Asbury Automotive
ABG
$3.94B
| $2.07M | ﹤0.01% |
+11,535
| New | +$1.93M |
|
2771
Toyota
TM
$220B
| $2.07M | ﹤0.01% |
15,131
-29,483
| -66% | -$4.11M |
|
2772
CALL
Wingstop
WING
$3.37B
| $2.06M | ﹤0.01% |
15,000
| – | – |
|
2773
Archer Daniels Midland
ADM
$37.4B
| $2.06M | ﹤0.01% |
22,232
+6,768
| +44% | +$625K |
|
2774
SiriusPoint
SPNT
$2.74B
| $2.06M | ﹤0.01% |
349,423
-381,380
| -52% | -$2.24M |
|
2775
Hercules Capital
HTGC
$3.12B
| $2.06M | ﹤0.01% |
+155,697
| New | +$2.12M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.